GlassScriptPhysician profile
Amanda A Henzel
NPI 1497801377
$1,740.68
in general payments reported to CMS, 2019-2025
20 companies · $504 in 2025
The $504 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $104 · 2021: $142 · 2022: $171 · 2023: $312 · 2024: $356 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,172.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $705.31 | 2019-2025 | |
| Astellas Pharma US INC | $199.37 | 2022-2025 | Veozah, Myrbetriq |
| Organon LLC | $129.31 | 2021-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $103.65 | 2021-2025 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Daiichi Sankyo INC. | $97.63 | 2019-2025 | Injectafer |
| Lilly USA, LLC | $78.11 | 2019-2024 | Zepbound, Jardiance |
| Sage Therapeutics, LLC | $70.42 | 2023-2025 | Zurzuvae |
| Exact Sciences Corporation | $67.33 | 2023-2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $65.95 | 2019-2021 | |
| Becton, Dickinson and Company | $31.17 | 2025 | Channel Drain |
| Coopersurgical, INC. | $30.81 | 2022-2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $26.88 | 2019 | |
| Channel Medsystems, INC. | $21.97 | 2023 | |
| Exeltis, USA INC. | $20.09 | 2023 | Slynd |
| Minerva Surgical, INC | $17.71 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $17.37 | 2025 | Qelbree |
| Octapharma USA, INC. | $15.85 | 2025 | Fibryga |
| Medtronic, INC. | $14.95 | 2023 | Closurefast |
| Axonics, INC. | $14.37 | 2022 | |
| Allergan, INC. | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Henzel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.